Live Breaking News & Updates on Airlangga university unair
Stay updated with breaking news from Airlangga university unair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
East Java Governor Khofifah Indar Parawansa expects the first phase of clinical trials of the Merah Putih vaccine conducted by Airlangga University (Unair) ...
Vaccination rate outside the Java-Bali region had increased and contributed 55.6 percent to the national average rate, according to Coordinating Minister for ...
The Merah Putih vaccine, developed by Indonesian scientists, could be utilized for both booster shots and regular COVID-19 vaccination, head of the National ...
Protocols for the clinical trial of the Merah Putih vaccine, developed by Airlangga University (Unair), have entered their final stage, head of the National ...
Surabaya , Unair develop mobile application for medical tourism antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.
Indonesia's educational actors celebrated this year's National Education Day on Sunday. They again celebrated this annual observance which commemorates ...
Unair rector pegs Red and White vaccine use in 2022 2 hours ago 2 hours ago Rector of Unair Prof Mohammad Nasih. (ANTARA Jatim/Willy Irawan) Surabaya, E Java (ANTARA) - Airlangga University (Unair) Rector Professor Mohammad Nasih is sanguine about the Red and White COVID-19 vaccine candidate currently being developed by university scientists being used in the government's vaccination program next year. "The vaccine candidate is projected to be usable about 10 to 11 months from now because its preclinical stages are not simple and short," Nasih noted in a statement that ANTARA quoted in Surabaya, the capital of East Java Province, on Tuesday.
Indonesia, Australia strengthen research collaboration antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.
Published on: Saturday, January 30, 2021 By: Antara News Researchers in the state-run vaccine maker PT Bio Farma in Bandung, West Java. JAKARTA: The second dose of China’s Sinovac vaccine has been administered across the country since January 27, mostly to healthcare workers at the frontlines of the fight against the Covid-19 pandemic. Since the first coronavirus infections emerged on March 2, 2020, Indonesia has chalked up 1,037,99 confirmed Covid-19 cases and 29,331 deaths, according to data recorded as of January 28, 2021. Under its vaccine programme, the government is targeting to inoculate 181.5 million people, free of charge, out of the total population of 271 million. ADVERTISEMENT Indonesia received 15 million doses of the bulk vaccine from Sinovac to be manufactured into individual doses by Bio Farma. The Food and Drug Supervisory Agency (BPOM) has issued a certificate for Good Manufacturing Practices (CPOB), or a permit, to Bio Farma to commence the production of Covid-19 drugs and vaccines.